SCHEMBL6645375

SCHEMBL6645375

CCC(C)NC(=O)c1cc(C(=O)O)cc(-c2nccs2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 1/20 0.42
F2 P00734 1/20 0.40
F10 P00742 1/20 0.40
PLG P00747 1/20 0.40
F7 P08709 1/20 0.40
F3 P13726 1/20 0.40
KAT6A Q92794 1/20 0.39
HDAC2 Q92769 1/20 0.39
THRB P10828 1/20 0.38
KCNB1 Q14721 3/20 0.38
P2RX3 P56373 2/20 0.38
P2RX2 Q9UBL9 2/20 0.38
KCNA5 P22460 1/20 0.38
HSPA5 P11021 1/20 0.37
HSPA9 P38646 1/20 0.37
SMPD3 Q9NY59 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL409512 0.86 P2RX3 (0.48) P2RX3P2RX2
SCHEMBL10187971 0.80 P2RX3 (0.44) F2F10PLGF7F3
SCHEMBL1435456 0.80 MAPK1 (0.61) MAPK1RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL6650208 0.79 NAAA (0.46) F2F10PLGF7F3
SCHEMBL407536 0.77 P2RX3 (0.50) P2RX3P2RX2
SCHEMBL6646087 0.76 GLRA3 (0.44) MAPK1RAB9AALDH1A1THRBNPC1
SCHEMBL2913713 0.75 MAPK1 (0.67) MAPK1RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL407659 0.74
SCHEMBL410232 0.74 P2RX3 (0.47) P2RX3P2RX2
SCHEMBL6171665 0.74 MAPK1 (0.55) MAPK1RAB9AALDH1A1NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP disclosed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO disclosed